View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United Kingdom |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2036-11-19 |
| Par Value | 100000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 600.00 |
| Coupon | 3.25 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 600.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This GSK Capital B.V. corporate medium term notes has a 3.25% fixed rate coupon paid on a annual basis. It was issued on November 19, 2024 with an issue size of 600.00 million EUR and matures on November 19, 2036 with a last coupon date of November 19, 2035. |
GSK Capital B.V., founded in the Netherlands, serves as a financial services entity focusing on innovative investment solutions. The company specializes in the issuance and management of various debt instruments aimed at optimizing funding strategies for its parent organization, GSK plc, a global healthcare leader.